Charles R. Ellefson is a notable inventor based in Chicago, IL, recognized for his contributions to the field of pharmaceuticals. He holds a total of 6 patents, showcasing his innovative spirit and dedication to advancing medical science. His work primarily focuses on compounds that exhibit significant pharmacological activities.

Latest Patents

Among his latest patents, Ellefson has developed the 8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof. These compounds are characterized by their formula, which includes various substituents that enhance their therapeutic potential. They are particularly useful due to their anti-arrhythmic, antimicrobial, and central nervous system activity. Another significant patent is for 2-Aryl-4-(1-piperazinyl)-3H-1,5-benzodiazepines, which serve as muscle relaxants. The detailed chemical structures and functionalities of these compounds highlight Ellefson's expertise in medicinal chemistry.

Career Highlights

Charles R. Ellefson has made significant strides in his career while working at G.D. Searle & Company. His innovative research has led to the development of various pharmaceutical compounds that address critical health issues. His contributions have not only advanced the field but have also paved the way for new therapeutic options.

Collaborations

Throughout his career, Ellefson has collaborated with esteemed colleagues, including John W. Cusic and Chi Min Woo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Charles R. Ellefson's work exemplifies the impact of innovation in the pharmaceutical industry. His patents reflect a commitment to improving health outcomes through scientific discovery. His contributions continue to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]